Epoprostenol therapy for pulmonary arterial hypertension: the first Polish experience

Pol Arch Intern Med. 2019 Jan 31;129(1):65-68. doi: 10.20452/pamw.4390. Epub 2018 Dec 13.

Authors

Grzegorz Kopeć¹, Marcin Waligóra¹, Kamil Jonas¹, Jakub Stępniewski¹, Wojciech Magoń¹, Piotr Podolec¹

Affiliation

¹ Department of Cardiac and Vascular Diseases, Faculty of Medicine, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland

PMID: 30543197
DOI: 10.20452/pamw.4390

No abstract available

MeSH terms

Adult
Antihypertensive Agents / therapeutic use
Epoprostenol / therapeutic use*
Female
Humans
Male
Middle Aged
Poland
Pulmonary Arterial Hypertension / drug therapy*

Substances

Antihypertensive Agents
Epoprostenol